When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TEVA - Amarin Stock Looks Attractive Despite U.S. Litigations
Teva Pharmaceutical Industries Limited American Depositary Shares
AMRN shares are up almost 30% last month, likely due in part to AMRN's success in keeping generics to 11% market share and the imminent European launch.
AMRN share price is still near its lows since it reported its REDUCE-IT data in 2018.
As the Nevada ANDA litigation ends as an AMRN loss, a generic (and pharma benefits managers) have filed anti-trust lawsuits against AMRN.
AMRN has a chance at winning its Delaware patent infringement lawsuit against Hikma and Health Net.
There were a number of updates last month in the pending AMRN v. generic and relevant litigations, in AMRN's favor.